Kaival Brands Innovations Group, Inc. (KAVL) is one of the major distributors of electronic nicotine delivery system (ENDS). One of the central products of the company is Bidi Stick which is a tamper-resistant and disposable flavored formulation. Bidi pouch is a flavored tobacco-free nicotine-based product as it contains chew base fillers and natural fibers.
Top 5 Tech Stocks to Buy in 2024
Don't let the chaos of rising interest rates, potential recession, tighter credit issues, higher oil prices, and incessant geopolitical issues chase you from the markets. Instead, just wait it out. With too much fear in the market, go bargain hunting with tech stocks. We have complied a report with the five of the best ways to profit within this industry.
"Top 5 AI Stocks to Buy in 2024."
Click here to sign up for our free report & newsletter, plus bonus offer "Elon Musk just Tiggered a BOOM in These Stocks"
Sponsored
The price of KAVL stock during the regular trading on January 6, 2022, was $0.76 with a phenomenal gain of 24.11%. At last check in the aftermarket, the stock dipped by 8.29%.
KAVL: Events and Happenings
On December 14, 2021, KVAL, which is the sole international distributor of formulations developed by Bidi Vapor, reported Bidi Vapor stated that 80% of adult contributors in cigarette smokers and e-cigarette users survey, held in the UK, favored the Bidi Stick over other options.
On December 6, 2021, KVAL reported about its collaboration with Koupon for the making of an electronic engagement platform that involved Koupon’s online promotion program. The collaboration gave its consumers many digital prospects who purchased the Bidi Stick.
On November 29, 2021, KVAL reported the outcomes of a study that found ENDS imitated the nicotine blood levels when the people smoked the usual combustible brand of cigarette, thus it satisfies the cigarette smoking addiction. On October 27, 2021, KAVL reported that Bidi Vapor announced about the issuance of administrative stay by FDA for its Marketing Denial Order of non-tobacco flavored Bidi Sticks Earlier FDA reviewed the Company’s appeal that the MDO should be withdrawn based on scientific evidence regarding the product.
On October 6, 2021, AVL reported that the company exhibited at the 2021 NACS show on October 5-8, 2021. On October 5, 2021, KAVL reported that the company planned to launch its formulations in the UK. On October 4, 2021, KAVL reported about the closure of a public offering of 4,700,000 shares and warrants to acquire approximately 3,525,000 shares of common stock. The gross proceeds as a result of the acquisition were up to $8.0 million.
KAVL: Key Financials
On October 14, 2021, KAVL reported its financial results for the third quarter ended July 31, 2021. Some of the highlights are as follows
Revenue and Assets
The revenues for the period of 2021 were $3.4 million as compared to the same period of 2020 when they were $32.4 million. Total current assets of the company were $23.8 million for Q3 2021.
Net Income/Loss per Share
Basic and diluted net loss for Q3 2021 was $3.4 million or $0.15 per share compared to the same period of 2020 when net income was $2.6 million or $0.05 per share.
Conclusion
KAVL stock is 90% down the past six months primarily due to the overall slow economic growth during the COVID-19 pandemic, yet the company’s stock leaped in the regular trading. The current aftermarket fall of the stock is because of an uncertain market environment that is not supporting the investors and stockholders, as suggested by the experts.
